ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1378

Associations Of Periodontitis (PD) With Established Seropositive Rheumatoid Arthritis are Independent of Smoking and Other Risk Factors

Ted R. Mikuls1, Jeffrey Payne2, Fang Yu3, Geoffrey M. Thiele4, Richard J. Reynolds5, Grant W. Cannon6, Jeffrey Markt7, David McGowan8, Gail S. Kerr9, Robert Redman10, Andreas M. Reimold11, Garth Griffiths12, Mark Beatty2, Shawneen Gonzalez2, Debra Bergman13, Bartlett C. Hamilton III14, Alan R. Erickson1 and James R. O'Dell15, 1Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 2College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 3University of Nebraska Medical Center, Omaha, NE, 4Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE, 5Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 7Otol-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, 8Dentistry, George E. Wahlen VA Medical Center, Salt Lake City, UT, 9Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 10Dentistry, Washington DC VA, Georgetown and Howard University, Washington, DC, 11Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, 12Dentistry, Dallas VA and University of Texas Southwestern, Dallas, TX, 13Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 14University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 15Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis, P. Gingivalis, Periodontitis, rheumatoid arthritis (RA) and risk assessment

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Periodontitis (PD) has been proposed as a risk factor in RA.  Reports have suggested that this association may be due to confounding from smoking , sicca syndrome, impaired oral hygiene, and HLA-DRB1 alleles (increased in rare forms of PD).  Recent speculation has focused on the role of P. gingivalis (Pg), an oral pathogen with the unique capacity of citrullinating protein.  We sought to examine the degree to which shared risk factors might explain or confound the relationship of PD with established RA.

Methods:

 RA cases (N=287) and osteoarthritis controls (N=330) underwent a standardized exam with PD defined using the criteria of Machtei et al (J Periodontol, 1990).  The percentage of sites with supragingival plaque served as a measure of oral hygiene.  HLA-DRB1 SE containing alleles were imputed using SNPs from the extended MHC.  Anti-Pg antibody to outer membrane antigen (OMA) was measured using ELISA.  Subgingival plaque was assessed for the presence of Pg using PCR.  Anti-cyclic citrullinated protein (aCCP) antibody and RF were measured by ELISA and nephelometry, respectively.  Associations of PD with RA (and aCCP positive RA) were examined using multivariable regression.

Results:

 Cases and controls were similar in all demographics assessed.  PD was more common in RA (35%, p = 0.022) and aCCP positive RA (n=240; 37%; p = 0.006) vs. controls (26%).  There were no RA-control differences in anti-Pg or the frequency of Pg positivity by PCR.  Anti-Pg antibody showed weak but statistically significant associations with both aCCP (r=0.14, p=0.022) and RF (r=0.19, p=0.001).  PD was associated with increased RA disease severity based on swollen joint count (p=0.004), DAS-28-CRP (p=0.045), total Sharp score (p=0.015), aCCP (p=0.011), and RF (p<0.001) levels.  Associations of PD with established aCCP positive RA were independent of all covariates examined (with similar, albeit non-significant ORs observed in never smokers).  In models not shown, associations were also independent of anti-Pg and Pg PCR status.

Table:  Multivariable associations of PD with RA (Odds Ratios and 95% CIs)

 

Full Cohort

 

Analysis Limited to Never Smokers

 

All RA

aCCP pos. RA

All RA

aCCP pos. RA

 

Periodontitis

 

1.36 (0.89, 20.6)

P = 0.153

1.59 (1.01, 2.49)

P = 0.043

1.37 (0.65, 29.1)

P = 0.409

1.87 (0.82, 4.25)

P = 0.157

 

HLA-DRB1 SE pos.

 

3.95 (2.68, 5.83)

P < 0.001

5.32 (3.44, 8.22)

P < 0.001

4.71 (2.55, 8.71)

P < 0.001

7.01 (3.43, 14.32)

P < 0.001

 

Ever smoking

 

1.93 (1.31, 2.83)

P = 0.001

1.97 (1.29, 2.99)

P = 0.002

—-

—-

*Full models not shown; covariates included age, gender, race, BMI, diabetes, marital status, oral dryness, oral hygiene, and education; MV  models limited to participants reporting either Caucasian or African American race/ethnicity

 

Conclusion: The relationship of PD with established aCCP positive RA does not appear to be driven by the prevalence of shared risk factors such as smoking or HLA-DRB1 SE nor does this relationship appear to be dependent on evidence of Pg infection.  Defining the precise role that Pg plays in early disease evolution and mechanisms linking PD with more severe RA remain important knowledge gaps for future research.


Disclosure:

T. R. Mikuls,

Roche/Genentech and Biogen IDEC Inc.,

2;

J. Payne,
None;

F. Yu,
None;

G. M. Thiele,
None;

R. J. Reynolds,
None;

G. W. Cannon,
None;

J. Markt,
None;

D. McGowan,
None;

G. S. Kerr,

Amgen, Abbott,

2;

R. Redman,
None;

A. M. Reimold,

UCB,

5,

Janssen Pharmaceutica Product, L.P.,

2,

Ardea,

2,

Novartis,

2,

Lilly,

2,

Pfizer,

2;

G. Griffiths,
None;

M. Beatty,
None;

S. Gonzalez,
None;

D. Bergman,
None;

B. C. Hamilton III,
None;

A. R. Erickson,
None;

J. R. O’Dell,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-periodontitis-pd-with-established-seropositive-rheumatoid-arthritis-are-independent-of-smoking-and-other-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology